US family flee Trump's trans policies to find ‘lovely' new home in Queenstown, NZ
'I would have never in a million years thought it would come to this in America. You know, we're taught to believe that it's the land of the free ... now we're realising that's not the case for every American.'
The Trump administration's policies felt especially threatening to Candace because they directly contradict her parenting mantra.
'This might sound a little crass, but my parenting philosophy was always, you be you as long as you're not an asshole.
'As a mom, I always knew my job was just to love my kids and follow their lead.'
Six days after Trump took office, the family got a notification from the gender affirming care department of their local children's hospital.
'They were no longer going to provide medical services to trans folks ... they would lose funding for other departments within the hospital if they did,' Candace said.
Candace says the move to Aotearoa just felt right. Photo / Supplied
It was then that the parents, who have always tried to give their kids an age-appropriate rundown of what's happening in the world, knew they had to activate their plan.
They started scoping countries most accepting of the LGBTQIA+ community and considered Spain, Portugal, Mexico and Canada. But when Brandon put a post on Facebook saying the family wanted to uproot, a former classmate who now lives in Wānaka encouraged them to consider Aotearoa.
'There was something in my gut that just immediately felt right,' Candace said.
With a landscape similar to Denver, Queenstown suited the family's outdoorsy nature, and they wouldn't face a language barrier.
'The kids are able to go to public school here, which is really nice.'
Queenstown suits the outdoorsy family. Photo / Supplied
Arriving in late July, Candace says their first impressions of their new home have met their tolerant and welcoming expectations.
'Everybody we've encountered has been so incredibly lovely,' Candace says, recounting how they got picked up from the airport by two of the senior staffers from Brandon's new employer, and lent them a car.
'Our landlord's just been amazingly lovely. She's like, 'we'll be your family away from family while you're here. You can put us on your kids' school forms as an emergency contact'.'
The family are hopeful the warm welcome continues when the kids start at their new school today.
'Chase is excited. Holt is your typical 12-year-old, 'he's like, miss school? As if'.'
Brandon's start as a sales rep for a winery in the Gibbston Valley, which sponsored their visas, came at the perfect time.
In what was a 'devastating blow', Candace was laid off when the family began to consider moving.
The high cost of living in Denver meant the family faced the prospect of temporarily relocating to Tennessee to stay with Candace's mother while saving for the move.
'Tennessee is notoriously awful for trans folks ... there's no way I could send Chase to school there,' Candace said.
Candace says her kids are resilient. Photo / Supplied
But she also acknowledges 'extreme privilege' enabled them to be able to leave the US at all.
'Financially it was quite a burden, but my best friend set up a GoFundMe for us, which helped alleviate some of that cost.
'I have a little bit of survivor's guilt almost that we were able to get out and there's still so many folks who need to and want to, just can't.'
Julia de Bres from national parents group New Zealand Parents and Guardians of Transgender and Gender Diverse Children says Aotearoa is still the country she'd feel safest raising a transgender child in, but 'we are currently experiencing similar pressures as other countries, with a rise in anti-trans ideologies and policies over the past few years'.
De Bres points to recent consultation on whether to restrict access to puberty blockers for young trans people, which is still under consideration by the Government, as well as the removal of Sport NZ's guiding principles for inclusion of trans people in sport in Aotearoa, as developments of great concern to the trans community.
In November last year, the Ministry of Health released its long-awaited evidence brief and a position statement on puberty-stalling hormones.
'The evidence brief found that the evidence supporting the effectiveness and safety was limited and of poor quality,' the ministry said.
As a result of the findings, the ministry is outlining an expectation that greater caution is used in prescribing the medication.
Other countries have also taken steps to restrict puberty blockers out of concern about a lack of robust evidence and rising prescribing rates.
But de Bres said she thinks most New Zealanders support the human rights of trans people to 'be themselves and be safe in this country'.
'We have a wonderful network of people within our communities working to keep everyone safe.'
Candace says her job as a mother is "just to love my kids and follow their lead". Photo / Supplied
Accessing gender-affirming care in Aotearoa will allow Chase to live fully as herself in her new home, Candace says.
Living regionally means the family may have to go to Christchurch occasionally for this, but mostly the 'things that Chase needs can be done [or monitored] through a family doctor'.
'A lot of people are greatly misinformed about what it actually entails. A doctor really described it best – as a pause button,' Candace says.
'There's no surgery... Chase just turned 10 a month ago, she hasn't entered puberty, so there's nothing to block.'
While they say they place no expectations for their kids, Candace and Brandon expect they'll call New Zealand home for a while yet.
'Our visas are for five years, which is fantastic. Our plan is to stay here long term ... I'm not going to uproot them again, while they're in school.
'So far everything has just sort of affirmed that this was the right decision and this was the right move for us.'
Also an associate professor at Massey University, de Bres is currently working on a research project on family support for transgender young people in Aotearoa.
She says young trans people deserve to feel safe in their families, schools, medical contexts and everywhere in their communities but 'there is so much that needs to be done to make this a reality'.
'A great start would be for the Government to better fund community organisations working to support trans young people, like Gender Minorities Aotearoa, RainbowYOUTH and OUTLine, who do so much work to support our young people. Improving access to gender-affirming care across the country is essential.
'The Government must stop importing hate from overseas – there is no reason for us to follow that dangerous path.'
The Ministry of Health says it will work closely with Health New Zealand and other partners to ensure young people experiencing gender incongruence or gender dysphoria have access to care that meets their physical and mental health needs and upholds their holistic range of rights as young people.
Where to get help:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NZ Herald
an hour ago
- NZ Herald
Trump sets a low bar for high-stakes summit and avoids key issues for Kyiv
He added, 'I may leave and say good luck, and that'll be the end.' Trump's own description of his goals for the negotiation, the most high-stakes international meeting yet in his second term, were telling — as much for what he omitted as for what he included. And that is what worries both the Ukrainians and Washington's European allies, who have committed to keep arming Ukraine no matter the outcome in Anchorage. What wasn't mentioned Ceasefire Zelenskyy, who has not been invited to join the talks in Alaska, has said that any agreement must start with a some kind of truce or ceasefire so that negotiations were not being conducted amid continued air attacks and territorial grabs. Trump has not stipulated that a truce must come first. Guarantees During his hour-long news conference, he never once mentioned security guarantees for Ukraine, intended to assure that Putin does not exploit a break in the fighting or new territorial gains as his moment to regroup, rearm and resume his effort to seize the whole country. Support Nor did Trump commit to making sure that Ukraine has the arms, intelligence and co-operation it needs to defend its territory and deter Russia from future attacks. His Vice-President, JD Vance, a longtime critic of American aid to Ukraine, was quite explicit during an appearance on Fox News. 'We're done with the funding of the Ukraine war business,' he said, insisting that the only way American arms would make it into Ukrainian hands would be if European allies bought and transferred them. A sense of haste Trump's comments came as the White House scrambled to make arrangements for one of the most hastily assembled summits of recent times. Usually, such sessions are preceded by detailed advance negotiations, with prearranged agreements and communiqués. Trump seemed to suggest that he was walking into this discussion with none of those, though European officials say they have seen evidence that, at lower levels, Russian and American officials are talking. Adding to the sense of haste, the White House has still not said where, exactly, the meeting will be held, how long it is expected to last or whether at the end Trump will preside over a meeting between Putin and Zelenskyy, two avowed enemies. Influencing Trump The risk now, as even some of Trump's Republican allies have conceded, is that Putin will see an opportunity to flatter Trump, play for time, and perhaps win him over to the Russian leader's own interpretation of events. Recent history suggests that Trump is inclined to accept Putin's version of reality. This year he suggested that Ukraine was responsible for the invasion of its own territory, and he refused to join America's traditional Western allies in voting for a United Nations resolution condemning Russia's aggression. Earlier this week, Zelenskyy worried aloud that Trump could be easily 'deceived'. For that reason, European and Nato officials — who mollified Trump at the alliance's summit in the Netherlands in June by pledging to spend 3.5% of their gross domestic product on defence over the next decade — are now carefully trying to hedge him in. They arranged a video call for tomorrow with Trump, aware that they will not be in the room in Alaska, so their power is limited to persuading him beforehand and risking his wrath by dissenting later. One of the most explicit warnings to Trump came from the Secretary-General of Nato, Mark Rutte, a former Netherlands Prime Minister who has invested heavily in developing a relationship with the President and devised the Nato summit to minimise the chances he would disrupt it. His bet paid off, and Trump sang the alliance's praises, rather than declare that it was 'obsolete', as he did in his first term. Rutte's guardrails But this week, Rutte was clearly drawing some guardrails for the coming negotiation. 'Next Friday will be important because it will be about testing Putin, how serious he is on bringing this terrible war to an end,' Rutte said on ABC. 'When it comes to full-scale negotiations, and let's hope that Friday will be an important step in that process', territory will be only one issue, he said. 'It will be, of course, about security guarantees, but also about the absolute need to acknowledge that Ukraine decides on its own future, that Ukraine has to be a sovereign nation, deciding on its own geopolitical future — of course having no limitations to its own military troop levels,' Rutte said. 'And for Nato, to have no limitations on our presence on the eastern flank.' The dealmaker Trump said none of that in his comments in the White House briefing room yesterday. But he made it clear that striking an agreement was the key. 'I make deals,' he said. Trump has made no secret of his desire to win a Nobel Peace Prize, and has claimed that he was the driving force in recent ceasefires or peace accords in disputes between India and Pakistan, Azerbaijan and Armenia, and other regional conflicts. 'What's the definition of a good deal?' Trump asked reporters. 'I'll tell you after I hear what the deal is, because there could be many definitions.' This article originally appeared in The New York Times. Written by: David E. Sanger Photograph by: David Guttenfelder ©2025 THE NEW YORK TIMES
NZ Herald
2 hours ago
- NZ Herald
How Trump's funding cuts threaten US science and global innovation
Khvorova built her career by thinking boldly, but if slowdowns and cuts to federal science funding continue, she'll be forced to winnow her ambitions. 'What is happening right now is absolutely suicidal,' said Khvorova, speaking softly in Russian-accented English. 'I will stop making drugs. I will reduce my lab from 30 people to five. I will stop training scientists.' With stunning speed, the Trump Administration has over the past six months cut research dollars, terminated grants and hit the brakes on federal funding, destabilising an 80-year-old partnership between the government and universities that has made the United States a scientific superpower. The policy twists may sound arcane, but to researchers, everything is at stake. Day-to-day, Khvorova's lab is bright and buzzing. Scientists are trying to develop cures for Huntington's disease or halt the muscle loss that comes with ageing. Longer term? 'I have no clue,' Khvorova said. The Trump Administration portrays its changes as a targeted correction. Officials say grants are being terminated because they touch on topics with which the Administration disagrees, such as increasing diversity in science. Funding to specific universities has been frozen because they haven't protected Jewish students, according to the Administration. Fundamental research, Trump officials vow, will thrive. 'The money that goes to basic and blue-sky science must be used for that purpose, not to feed the red tape that so often goes along with funded research,' Michael Kratsios, director of the White House Office of Science Technology and Policy, said in a speech at the National Academy of Sciences in May. From left, Gregory Smith, Nathan Gioacchini and Philip Soglo synthesise strands of RNA at U-Mass Chan Medical School. Photo / Kate Wool, The Washington Post In contrast, a recent report from the American Association for the Advancement of Science found that President Donald Trump's budget request for 2026 – including a 40% cut to the National Institutes of Health – would slice the nation's basic research portfolio by about a third. A new report from the Congressional Budget Office found that a 10% cut to the NIH budget would result in two fewer drugs invented per year, a gradual decline that would go into full effect in 30 years. The Trump Administration's science agenda is getting pushback in courts, in Congress and at the state level, but the impacts are being felt in research institutions across the country. As of August 1, the Chan Medical School had a US$37 million ($62m)shortfall in funding because of long delays at the National Institutes of Health. Khvorova is no stranger to doing science under challenging conditions. She trained at Moscow State University in the waning days of the Soviet Union, when there was sometimes no hot water, no reagents for experiments, no salaries. Even that has not prepared her for the abrupt policy swings that threaten the unique American research system. 'We are working on developing cures, which are not politically oriented,' Khvorova said. 'Democrats age, and Republicans age.' Disruptions will ripple over decades, since no one can predict what science breakthroughs in the lab will turn into world-changing innovations. Khvorova's work built off years of federally funded research into soil-dwelling microscopic roundworms that revealed short strands of RNA perform like symphony conductors, controlling the activity of genes and turning their volume down. Worcester, a gritty former mill city in Central Massachusetts, is home to two Nobel laureates and an RNA Therapeutics Institute that has spawned 12 start-ups. Alnylam Pharmaceuticals, a company based on the phenomenon originally discovered in roundworms in labs at Chan Medical School and the Carnegie Institution of Washington, has discovered six drugs now approved for diseases that include rare genetic conditions and high cholesterol. The company's market capitalisation has soared to more than US$50 billion, and it has 2200 employees. Basic research 'is almost like the starter when you bake sourdough bread. You can't make the bread without it,' said John Maraganore, who led Alnylam for nearly two decades before he stepped down in 2021. 'Girls just wanna have (NIH) funding' In the labyrinthine, slightly cluttered labs at Chan Medical School, scientists tend to high-end instruments with geeky names like 'Dr Oligo', using them to synthesise strands of RNA aimed at treating fatal forms of dementia or diseases that cause muscles to waste away. Under sterile hoods, they grow millions of mouse liver cells for experiments. In a small room called the 'wormhole', decorated with colourful worms hanging from the door jamb like icicles, Victor Ambros, a Nobel Prize-winning worm biologist, zooms in on mutant roundworms wriggling across a yellowish agar gel. Unlike Harvard University, which has had billions of dollars in funding choked off by the Trump Administration, Chan hasn't been targeted. But it is not untouched. Like hundreds of other institutions across America, it has been thrown off stride day-to-day and week-to-week by the Trump Administration's unprecedented efforts to downsize and reshape the agencies that support science. Uncertainty looms over nearly every experiment and conversation. Slogans, not scientific sketches, are scrawled on the frosted glass wall of one office: 'We want scientific data, not alternative facts!' 'Girls just wanna have (NIH) funding' 'Science Not Silence!' More than a dozen NIH grants, out of several hundred, have been terminated, though they are tangled up in lawsuits challenging the Trump Administration's actions. About 200 employees have been laid off or furloughed, about 3% of the medical school's 6500 employees. A hiring freeze has been in place since March. Graduate school offers to nearly 90 young biomedical scientists were rescinded, though 13 spots were salvaged for next year's class. 'We have this feeling of extreme uncertainty, in a context where, previously, we could depend upon a robust system, a merit-based system that was predictable for the right reasons – the best science will get funded,' said Ambros, who shared the Nobel in medicine last year. Jesse Lehman, a graduate student who focuses on understanding the speed and dynamics of immune defences against pathogens, became hooked on science when he first felt the rush of discovering things no one else knew. There are no guarantees in this career – the contest for federal funding is exceptionally competitive. But what has fuelled the system is its reliability. The federal Government funds the best research, year after year, and scientists chase grants without worrying that the funder may lose interest in neuroscience or immunology and decide instead to buy a sports team. But now, federal funding may be there one moment and gone the next. 'I have this fear that the career that I've worked 10 years on developing just may not be viable,' Lehman said. The 20-year path to success Research institutions nationwide experience layoffs and uncertainty due to the funding reductions. Photo / Kate Wool, The Washington Post In textbooks, science is a steady march of progress. In the lab, it's an iterative process – filled with detours and dead ends that sometimes turn out to be surprises that push the field forward. In 2006, Chan biologist Craig Mello shared the Nobel Prize with Stanford University biologist Andrew Fire for the discovery of a phenomenon called RNA interference: short double strands of RNA could silence genes. It is a profound biological mechanism shared not just by tiny worms, but by humans. Other scientists built on the work, capturing the interest of venture capitalists and pharma companies. Many human diseases are caused by errant genes. What if, instead of treating patients' symptoms, doctors could give their patients drugs that just shut off the problematic ones? More than a billion dollars flowed into start-ups, but biology turned out to be a bit more complicated. Investor ebullience evaporated. Alnylam, an RNAi company, began trading below the amount of cash it had on hand, meaning investors thought its stock was less valuable than the money it had in the bank. Years of science – including a lot of chemistry – eventually turned a profound biological mechanism into a new class of safe effective drugs. 'Sickness doesn't have political boundaries,' said Phillip Zamore, a co-founder of Alnylam and a professor of biomedical sciences. 'Everyone deserves a better treatment for their disease, and I just want to make that possible. And I can't do that if my lab, my university, my colleagues' ability to do science is destroyed.' In the past few years, several biotech companies have spun out of Chan, including Comanche Biopharma, which is focused on a treatment for pre-eclampsia – a complication of pregnancy – and Atalanta Therapeutics, which is searching for cures for neurodegenerative diseases. Khvorova, a co-founder of both companies, came to the US with very little money in the mid-1990s, intending to check a box on her CV and stay a year or two. Instead, she became a 'typical example of the American Dream', as she puts it. She's an inventor named on nearly 250 patents. She just scooped up one of the most prestigious prizes in biomedical research, with a US$2.7m award. She should be on top of the world. But as she walked to her lab on a recent Tuesday, she gestured sadly at a collection of empty champagne bottles sitting high up above the cabinets in the lounge outside. Each bottle, she noted, is a trained graduate student – a reminder that most of next year's class was turned away.
Otago Daily Times
4 hours ago
- Otago Daily Times
Trump in element but summit unlikely to end war
"I love deadlines," Douglas Adams, author of The Hitchhiker's Guide to the Galaxy , said. "I like the whooshing sound they make as they fly by." United States President Donald Trump sets deadlines for more complicated reasons that purport to be tactical, but he too is addicted to the whooshing sound they make when he breaks them. His latest display of disdain for the deadlines he sets himself began in mid-July, when he gave Russia a 50-day deadline to agree to a ceasefire in its war against Ukraine. A week later, in an apparent fit of temper over President Vladimir Putin's relentless nightly attacks on Ukrainian cities, Trump moved the deadline up by a month, to August 8. Russia's penalty for missing that deadline was allegedly going to be American "secondary tariffs" against other countries that continue to buy Russian oil, notably China, India and Turkey. "I used trade for a lot of things, but it's great for settling wars," Trump boasted — only to discover, not for the first time, that his intended targets were able to push back. Trump declared, again before the actual deadline rolled around, that India's new tariff would be 50%, not 25%, if it did not stop buying heavily discounted Russian oil. Prime Minister Narendra Modi immediately declared that he was ready to "pay a huge price" rather than let the US dictate India's trade policies — and Trump did not even try it on with China or Turkey. So with no leverage in Moscow, his deadline for a Russian ceasefire passed unmentioned. Instead, he sent his favourite emissary, real estate developer Steve Witkoff, to make a new offer: a one-on-one meeting between Trump and Putin in which the two men would make a deal without the Ukrainians, the European Nato countries, or anybody else present. Putin jumped at the chance, as it will be his first face-to-face meeting with a US president since 2021. (He was being boycotted because of his invasion of Ukraine, but this is presumably one of Russia's rewards for agreeing to a "summit".) However, what Trump hopes to get out of it is less obvious. Although Trump is very much in thrall to Vladimir Putin, who he mistakenly believes to be his personal friend, he knows that a full Russian conquest of Ukraine would not look good on his record. His real goal is to win the Nobel Peace Prize in order to end the shame of having seen Barack Obama get one first. For that, he needs a longer-lasting "peace". This need not be a permanent peace settlement that includes an independent Ukraine. Trump really believes in "America First", and Ukraine's long-term fate is of no interest to him. But he must persuade Putin to accept only a partial victory now (and maybe final conquest later) in order to portray himself to the Norwegian Nobel committee as a plausible peacemaker. This explanation sounds so stupid and ridiculous that people have difficulty in taking it seriously, but it does explain why Trump has tried so hard to bully first one side (Ukraine), then the other side (Russia), and now back to Ukraine, into signing that kind of nothing-settled ceasefire. If you still question that analysis, consider the fact that Trump regularly indulges in extended public rants about the sheer injustice of Obama getting a Nobel Peace Prize and leaving him still without one. So when Putin dangles the prospect of a one-on-one summit before Witkoff, of course Trump is tempted, even if it would impose a disadvantageous ceasefire on Ukraine. However, there will probably not be a complete sell-out of Ukraine in Alaska, for two reasons. The first is that Putin, rightly or wrongly, is convinced that he is now winning the war by sheer weight of numbers, and that it is only a matter of time until Ukraine collapses. In that case, why would he now trim his maximal aspirations for the sake of a ceasefire? Those aspirations include Russian sovereignty over Crimea and the four south-eastern regions of Ukraine (including the yet unconquered parts), and permanent neutrality and a much-reduced army for Ukraine. In the long run, Putin aspires to "reunite" all of Ukraine with Russia under one pretext or another, but a decisive military victory might make it possible now. The other reason to assume that the Alaskan summit is unlikely to end the war is the fact that if Trump does completely sell out Ukraine, the Ukrainians will go on fighting anyway. They would be fighting at a worse disadvantage and facing a bigger likelihood of eventual conquest, but they know that wars can have unpredictable outcomes until the next-to-last moment. And whatever happens, Trump will go on setting deadlines and then missing them. Just like he did in the real estate business. • Gwynne Dyer is an independent London journalist.
